F16.988 ICD-10-CM Code: Hallucinogen use, unspecified with other hallucinogen-induced disorder
F16.988 maps to CMS-HCC V28 137. A source-labeled RAF reference is available. Confirm the documented diagnosis and applicable coding requirements. MEAT criteria · RAF Calculator · HCC coding software
HCC Buddy Code Card
Digital ICD-10 code-book layout with official code detail, always-visible risk models, Code Trumping, and Buddy coding guidance.
FY 2026 Apr update / Mental, Behavioral and Neurodevelopmental disorders (F01-F99) / Mental and behavioral disorders due to psychoactive substance use (F10-F19)
F16.988
Billable / SpecificICD-10-CMOfficial ICD-10-CMCodebook guidanceHallucinogen use, unspecified with other hallucinogen-induced disorder
A condition where someone uses hallucinogenic drugs (like LSD or psilocybin) and experiences other drug-related health problems as a result, but the specific type of hallucinogen is not identified.

Buddy Insight
This code captures other specified hallucinogen-induced disorders in patients with unspecified hallucinogen use pattern, covering conditions like substance-induced sleep disorders, sexual dysfunction, or other neurocognitive effects not classified under mood, anxiety, psychosis, or HPPD categories.
CMS-HCC V28
MappedHCC 137
Coefficient HCC 137: 0.424 (Community Non-Dual Aged (CNA))
CMS-HCC V24
HistoricalHistorical
Not used for CY2026 payment
ACA/HHS
MappedHCC 082
Code-level coefficient reference
ESRD/PACE
MappedHCC 55
Code-level coefficient reference
RXHCC
N/A—
Not mapped
Code Book Path
Inclusion Terms
OfficialNo inclusion terms are included in this display for F16.988. Check the code and parent instructions in the Code Book.
Excludes 2
Official- symptoms, signs and abnormal clinical laboratory findings, not elsewhere classified (R00-R99)Inherited from F01-F99
Related Codes
Includes
Official- disorders of psychological developmentInherited from F01-F99, F16
- ecstasyInherited from F01-F99, F16
- PCPInherited from F01-F99, F16
- phencyclidineInherited from F01-F99, F16
Excludes 1
Official- hallucinogen abuse (F16.1-)Inherited from F16.9
- hallucinogen dependence (F16.2-)Inherited from F16.9
Code First
OfficialNo Code First sequencing instructions are included in this display for F16.988. Check the code and parent instructions in the Code Book.
Use Additional
OfficialNo Use Additional Code instructions are included in this display for F16.988. Check the code and parent instructions in the Code Book.
Code Also
OfficialNo Code Also instructions are included in this display for F16.988. Check the code and parent instructions in the Code Book.
Buddy Documentation Tip
MEAT Support
Audit Caution
Common Mistakes
Current with CMS: FY2026 ICD-10-CM Apr 1 update (effective Apr 1 – Sep 30, 2026) · CMS-HCC V28, 100% phased in for payment year 2026. FY2027 code set already staged for October 1, 2026. How HCC Buddy stays current →
Is F16.988 an HCC code?
Yes. F16.988 (Hallucinogen use, unspecified with other hallucinogen-induced disorder) maps to HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications under the CMS-HCC V28 risk adjustment model, with a source-labeled community non-dual aged reference coefficient of 0.424. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes. It is billable for payment year 2026.
Coder answer: F16.988 is billable and maps to V28 HCC 137, Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications. Open it in the Code Book for the tabular path, RAF, and MEAT checklist.
- Code
- F16.988
- Description
- Hallucinogen use, unspecified with other hallucinogen-induced disorder
- HCC (V28)
- HCC 137 — Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications
- RAF reference coefficient
- 0.424
- Billable
- Yes
- Payment year
- 2026
HCC Category Mapping
These are source-labeled model coefficients, not member totals. A category may still be removed by hierarchy or model cleanup rules. Weights are not directly comparable across models: CMS-HCC V28 and V24 use Community, Non-Dual, Aged; ESRD uses the dialysis continuing-enrollee model; RxHCC is the Part D continuing-enrollee, non-low-income, aged weight (a larger scale than CMS-HCC). ACA/HHS has no single weight — it varies by metal level. Actual per-patient RAF contribution depends on member context, hierarchy and cleanup rules, interactions, and the model year used by the payer. V28 is the CMS-HCC model phased in over payment years 2024–2026; V24 remains available for historical review.
Work F16.988 in the Code Book — tabular path, V28 RAF reference, and MEAT checklist →
MEAT review for F16.988
For F16.988, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule.
- MMonitor: signs, symptoms, disease progression, or lab trending documented in the note
- EEvaluate: test results, medication response, or physical findings reviewed by the provider
- AAssess: explicit mention in the assessment or plan with acknowledgment of status
- TTreat: medication, referral, procedure, therapy, or counseling tied to the diagnosis
Coder workflow notes
Get the V28 mapping + MEAT cheat sheet
One printable reference: check representative V28 mappings and the documentation reminders your note needs. Free, no card.
Free PDF. No card. Unsubscribe anytime.
What This Code Means
F16.988 is the ICD-10-CM diagnosis code for hallucinogen use, unspecified with other hallucinogen-induced disorder. A condition where someone uses hallucinogenic drugs (like LSD or psilocybin) and experiences other drug-related health problems as a result, but the specific type of hallucinogen is not identified. F16.988 sits in the ICD-10-CM chapter for mental, behavioral and neurodevelopmental disorders (f01-f99), within the section covering mental and behavioral disorders due to psychoactive substance use (f10-f19).
Under the CMS-HCC V28 risk adjustment model, F16.988 maps to Drug Use Disorder, Moderate/Severe, or Drug Use with Non-Psychotic Complications (HCC 137) with a source-labeled community, non-dual, aged reference coefficient of 0.424. For CY2026 non-PACE Medicare Advantage, CMS uses 100% of the 2024 CMS-HCC model (V28). PACE uses a separate model blend. Source-labeled code-level coefficients are references, not member totals. Actual contribution depends on complete member context, hierarchy and cleanup rules, interactions, and model year. HCC Buddy's RAF Calculator supports CMS-HCC V28 PY2026 and shows no score unless every required source and calculation check passes.
Use this code when hallucinogen use is documented but the specific substance cannot be determined and other induced disorders are present. For F16.988, confirm that the documentation supports the diagnosis and meets the applicable coding, encounter, program and payer requirements. MEAT (Monitor, Evaluate, Assess, or Treat) is a review mnemonic, not a universal CMS coding rule. When documentation is ambiguous, coders should issue a provider query rather than assume the highest-specificity variant.
HCC Buddy maintains structured V28 and V24 mapping, source-labeled coefficient references, and MEAT documentation criteria for F16.988 sourced directly from the CMS-HCC risk adjustment model files and the CMS ICD-10-CM code set.
Coding Tips
- •Use this code when hallucinogen use is documented but the specific substance cannot be determined and other induced disorders are present
- •Ensure documentation specifies what hallucinogen-induced disorder is present (e.g., psychosis, mood disorder) for accurate coding
Clinical Significance
This code captures other specified hallucinogen-induced disorders in patients with unspecified hallucinogen use pattern, covering conditions like substance-induced sleep disorders, sexual dysfunction, or other neurocognitive effects not classified under mood, anxiety, psychosis, or HPPD categories.
Documentation Requirements
- ✓Documentation of hallucinogen use
- ✓Specific identification of the induced disorder
- ✓Causal link between hallucinogen use and the condition
- ✓Documentation that the disorder does not fit mood, anxiety, psychotic, or HPPD categories
- ✓Provider query for abuse vs dependence clarification
Commonly Confused Codes
- •F16.99: With unspecified induced disorder; use only when the disorder truly cannot be identified
- •F16.94: With induced mood disorder; use when mood symptoms predominate
- •F16.980: With induced anxiety disorder; use when anxiety is the primary complication
- •F16.288: Hallucinogen dependence with other induced disorder; more specific regarding dependence

